tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSHA Stock Latest News

Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
RatingsRegulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
12d ago
TSHA
Taysha Gene Therapies announces progress across TSHA-102
PremiumThe Fly
Taysha Gene Therapies announces progress across TSHA-102
12d ago
TSHA
Taysha Gene Therapies price target raised to $11 from $8 at Wells Fargo
PremiumThe Fly
Taysha Gene Therapies price target raised to $11 from $8 at Wells Fargo
13d ago
TSHA
Taysha Gene Therapies rated Buy versus Early-Stage at Goldman Sachs
PremiumThe Fly
Taysha Gene Therapies rated Buy versus Early-Stage at Goldman Sachs
2M ago
TSHA
Taysha price target raised to $19 from $13 at Cantor Fitzgerald
PremiumThe Fly
Taysha price target raised to $19 from $13 at Cantor Fitzgerald
2M ago
TSHA
Citizens JMP healthcare analysts hold an analyst/industry conference
PremiumThe FlyCitizens JMP healthcare analysts hold an analyst/industry conference
2M ago
BNTC
CRSP
FDA appoints Richard Pazdur as Director of CDER
Premium
The Fly
FDA appoints Richard Pazdur as Director of CDER
2M ago
AZN
BMY
Taysha Gene Therapies price target raised to $8 from $6 at Citizens JMP
Premium
The Fly
Taysha Gene Therapies price target raised to $8 from $6 at Citizens JMP
2M ago
TSHA
Taysha Gene Therapies Advances TSHA-102 Program
PremiumCompany Announcements
Taysha Gene Therapies Advances TSHA-102 Program
2M ago
TSHA
Taysha Gene Therapies’ Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Taysha Gene Therapies’ Earnings Call Highlights Progress and Challenges
2M ago
TSHA
Taysha Gene Therapies: Advancing REVEAL Study and Mitigating Regulatory Risks Earns Buy Rating
PremiumRatings
Taysha Gene Therapies: Advancing REVEAL Study and Mitigating Regulatory Risks Earns Buy Rating
3M ago
TSHA
Taysha Gene Therapies files automatic mixed securities shelf
PremiumThe Fly
Taysha Gene Therapies files automatic mixed securities shelf
3M ago
TSHA
Taysha Gene Therapies Amends Sales Agreement, Expands Offering
PremiumCompany AnnouncementsTaysha Gene Therapies Amends Sales Agreement, Expands Offering
3M ago
8K
TSHA
Taysha Gene Therapies reports Q3 EPS (9c), consensus (9c)
Premium
The Fly
Taysha Gene Therapies reports Q3 EPS (9c), consensus (9c)
3M ago
TSHA
Taysha Gene Therapies sees cash runway into 2028
Premium
The Fly
Taysha Gene Therapies sees cash runway into 2028
3M ago
TSHA
Is TSHA a Buy, Before Earnings?
PremiumPre-Earnings
Is TSHA a Buy, Before Earnings?
3M ago
TSHA
Taysha Gene Therapies’ REVEAL Adult Study: A New Hope for Rett Syndrome?
PremiumCompany Announcements
Taysha Gene Therapies’ REVEAL Adult Study: A New Hope for Rett Syndrome?
3M ago
TSHA
Taysha Gene Therapies initiated with a Strong Buy at Raymond James
PremiumThe Fly
Taysha Gene Therapies initiated with a Strong Buy at Raymond James
3M ago
TSHA
Strategic Advantage and Positive Outlook: Taysha Gene Therapies Maintains Buy Rating
PremiumRatings
Strategic Advantage and Positive Outlook: Taysha Gene Therapies Maintains Buy Rating
3M ago
TSHA
Taysha Regains Full Rights to TSHA-102 Program
PremiumCompany AnnouncementsTaysha Regains Full Rights to TSHA-102 Program
3M ago
8K
TSHA
Taysha Gene Therapies regains full rights to TSHA-102 program
Premium
The Fly
Taysha Gene Therapies regains full rights to TSHA-102 program
3M ago
TSHA
Taysha Gene Therapies price target raised to $9 from $8 at BofA
Premium
The Fly
Taysha Gene Therapies price target raised to $9 from $8 at BofA
3M ago
TSHA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >